Reported / Citable
Background
QueerDoc is a telehealth provider that treats gender dysphoria, including by prescribing puberty blockers and hormones to some minor patients. After the President issued executive orders opposing federal support for gender-affirming care for minors, the Department of Justice served QueerDoc with an administrative subpoena seeking records for an investigation of possible federal healthcare offenses.
The subpoena relied on authority in the Health Insurance Portability and Accountability Act, or HIPAA, that allows the Attorney General to demand evidence during an investigation of a federal healthcare offense. A Washington federal judge quashed the subpoena in full, finding that DOJ’s stated investigation was a pretext for the administration’s announced goal of eliminating gender-affirming care. DOJ appealed.
The Court’s Holding
A divided Ninth Circuit reversed. The majority held that DOJ acted within HIPAA’s subpoena authority because suspected violations of federal drug-misbranding law may qualify as federal healthcare offenses, DOJ followed the required procedures, and the requested material was relevant to an authorized investigation.
The provider also failed, the majority concluded, to carry the heavy burden of proving an improper purpose. Government action is presumed regular, and public statements opposing a form of medical treatment do not by themselves establish that an otherwise authorized subpoena was issued in bad faith. The President may direct enforcement priorities that advance broader policy goals so long as the agency remains within authority Congress granted.
The ruling does not require QueerDoc to produce every requested record immediately. The district court had resolved only the bad-faith issue and had not decided whether the demands were overbroad or unduly burdensome, so those objections remain open on remand. Judge Paez dissented, reasoning that the district court’s factual bad-faith finding deserved deference and was supported by DOJ’s statements, changing explanations, departure from enforcement norms, and intrusive demands.
Key Takeaways
- A recipient seeking to quash a federal administrative subpoena for improper purpose faces a demanding evidentiary burden and a presumption that officials acted regularly.
- An administration’s public hostility toward the regulated activity does not alone invalidate a subpoena that fits a congressionally authorized investigation.
- Healthcare providers should separately preserve relevance, breadth, burden, privilege, and patient-privacy objections rather than relying only on alleged political motivation.
- The decision recognizes federal drug-misbranding investigations as a potential basis for HIPAA administrative-subpoena authority.
- On remand, QueerDoc may still narrow or defeat particular demands by showing overbreadth or undue burden.
Why It Matters
California healthcare providers operating in politically contested fields should expect courts to distinguish enforcement motive from statutory authority. Evidence of policy alignment, even strong public rhetoric, will usually be insufficient without specific proof that the asserted investigation is not genuine.
The practical response to an aggressive subpoena is therefore a record-focused one: identify how each demand relates to the suspected offense, quantify compliance burdens, protect patient information, and challenge requests that exceed the investigation. The dissent also signals that unusual agency statements and departures from normal practice can matter when supported by a developed factual record.